These 2 Biotech Stocks Are Set to Soar

Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins. Investing in biotech companies, especially relatively small ones, can be a double-edged sword. Their shares often soar on strong clinical trial or regulatory news, but they can lose much of their value overnight if a study's results don't go their way. That makes many biotech stocks somewhat risky investments, but some could deliver excellent results for those who can stomach the risk. Two biotech co ...